ArticleBriefings in bioinformatics2026
GeNePi: a graphics processing unit enhanced next-generation bioinformatics pipeline for whole-genome sequencing analysis.
Article in Briefings in bioinformatics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- New insights into neurodevelopmental disorders by whole genome sequencing of 100 families from Italy.NPJ genomic medicine · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
Abstract
Next-generation sequencing (NGS) has revolutionized genome biology by enabling rapid whole-genome sequencing (WGS) and driving its adoption in research and clinical settings. However, the high-throughput nature of NGS and the complexity of downstream analyses demand robust computational solutions. We present GeNePi, a modular bioinformatic pipeline for efficient and accurate analysis of WGS short paired-end reads. GeNePi is a genomics analysis pipeline built on the Nextflow framework, integrating graphics processing unit (GPU)-accelerated algorithms from NVIDIA Clara Parabricks to enable high-performance variant discovery. The pipeline supports multiple workflow configurations and automates the detection of a broad range of genomic variants, including single-nucleotide variants and small insertions/deletions via GPU-accelerated HaplotypeCaller, copy number variants (CNVs) using CNVkit, and structural variants through a consensus approach combining Manta, Lumpy, BreakDancer, and CNVnator. Additionally, GeNePi incorporates MELT for the detection of mobile element insertions, providing a comprehensive framework for variant discovery and characterization. Benchmarking on synthetic and real datasets demonstrates high accuracy and performance comparable to state-of-the-art tools such as Genome Analysis ToolKit (GATK), establishing GeNePi as a scalable solution for comprehensive WGS analysis. These features make GeNePi a valuable instrument for large-scale analyses in both research and clinical contexts, representing a key step towards the establishment of National Centers for Computational and Technological Medicine.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.